Ikena Oncology Inc (IKNA)

Ikena Oncology Inc Azioni (IKNA) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	100.00% -	0.659	1.185	2.004	5.313
Operating Expenses	19.24% 18.23	22.57	20.69	20.49	20.83
Operating Income/Loss	16.81% -18.23	-21.91	-19.50	-18.49	-15.52
Nonoperating Income/Loss	2.107	-	2.16	1.375	1.296
Income/Loss From Continuing Operations Before Tax	17.97% -16.12	-19.65	1.185	-17.11	-14.22
Income Tax Expense/Benefit	0.027	-	-	-	-
Income/Loss From Continuing Operations After Tax	17.15% -16.15	-19.49	-17.34	-17.11	-14.22
Net Income/Loss	17.15% -16.15	-19.49	-17.34	-17.11	-14.22
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,259% 48.26	2.0461	43.44	39.29	36.26
Diluted Average Shares	2,259% 48.26	2.0461	43.44	39.29	36.26
Basic Earnings Per Share	17.50% -0.33	-0.40	-0.40	-0.44	-0.39
Diluted Earnings Per Share	17.50% -0.33	-0.40	-0.40	-0.44	-0.39
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-